Novel Case of CT-Guided Percutaneous Revascularization

This article originally appeared here.
Share this content:
Novel Case of CT-Guided Percutaneous Revascularization
Novel Case of CT-Guided Percutaneous Revascularization

MONDAY, Nov. 23, 2015 (HealthDay News) -- The first case of computed tomography-guided percutaneous revascularization of coronary occlusion in man using a wearable, hands-free computer with a head-mounted display has been described. The report was published online Nov. 19 in the Canadian Journal of Cardiology.

Maksymilian P. Opolski, M.D., from the Institute of Cardiology in Warsaw, Poland, and colleagues describe the first case of successful computed tomography-guided percutaneous revascularization of a chronically occluded right coronary artery in a 49-year-old male patient. The case involved novel application of a wearable hands-free computer with a head-mounted display, which was worn by interventional cardiologists in the catheterization laboratory.

The researchers note that the operators could clearly visualize the distal coronary vessel with projection of three-dimensional computed tomographic reconstructions onto the screen of virtual reality glass. Furthermore, they were able to verify the direction of advancement of the guide wire relative to the occluded vessel segment course.

"This case demonstrates the novel application of wearable computers for display of computed tomography angiography data sets in the catheterization laboratory that can be used for better planning and guidance of interventional procedures," the authors write. "We believe wearable computers have a great potential to optimize percutaneous revascularization, and thus favorably affect interventional cardiologists in their daily clinical activities."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

WHO: Vaccine Hesitancy a Major Global Health Threat

WHO: Vaccine Hesitancy a Major Global Health Threat

Percentage of U.S. children 19 to 35 months who have not been vaccinated has quadrupled since 2001

FDA Down to 5 Weeks of Funding to Review New Drug Applications

FDA Down to 5 Weeks of Funding to ...

Agency cannot accept new fees or applications until the shutdown is over

FDA Approves First Generic Version of Epilepsy Drug Sabril

FDA Approves First Generic Version of Epilepsy Drug ...

Generic equivalents held to same vigorous manufacturing standards as brand-name drugs

is free, fast, and customized just for you!




Already a member?

Sign In Now »